{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:55Z","timestamp":1762004275318},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T00:00:00Z","timestamp":1208908800000},"content-version":"vor","delay-in-days":9701,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[1981,10]]},"abstract":"<jats:p>The suitability of using [1\u2010<jats:sup>14<\/jats:sup>C]phytanic acid as a substrate for the diagnosis of Refsum's disease has been examined. Normal fibroblasts cultured in medium containing low concentrations of foetal calf serum (0.5 %) oxidised added [1\u2010<jats:sup>14<\/jats:sup>C]phytanic acid to <jats:sup>14<\/jats:sup>CO<jats:sub>2<\/jats:sub> only slowly up to about 2 days; beyond this period a marked stimulation in oxidation was observed. Easily measurable conversion of the radiolabeled acid (from 1.5 to 5.0%) was obtained by numbers of cells at least one order of magnitude fewer than previously described. Fibroblasts from adult patients with Refsum's disease displayed about 5\u201310 % of the normal mean activity. Small differences in residual activity were observed in the different cell lines. However, no obvious relationship was found between the degree of residual activity, the level of plasma phytanate, and the patient's clinical condition and history.<\/jats:p>","DOI":"10.1111\/j.1399-0004.1981.tb01029.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T23:34:31Z","timestamp":1279496071000},"page":"247-253","source":"Crossref","is-referenced-by-count":29,"title":["Diagnosis of Refsum's disease using [1\u2010<sup>14<\/sup>C]phytanic acid as substrate"],"prefix":"10.1111","volume":"20","author":[{"given":"A.","family":"Poulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"Carey W. C. D.Petersen&E.Ravenscroft(1981) Unpublished data."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91005-5"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196911062811903"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106058"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3922.1268"},{"key":"e_1_2_1_7_1","first-page":"1","article-title":"The chemistry and biochemistry of phytanic, pristanic and related acids","volume":"4","author":"Lough A. K.","year":"1973","journal-title":"Prog. Chem. Fats Other Lipids"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_9_1","first-page":"692","article-title":"Metabolism of phytol\u2010U\u2010WC","volume":"7","author":"Mize C. E.","year":"1966","journal-title":"J. Lipid. Res."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(76)90194-7"},{"key":"e_1_2_1_11_1","unstructured":"Pollard A. C. G.Wise&A.Poulos(1980a) Unpublished data."},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","DOI":"10.5694\/j.1326-5377.1980.tb100764.x","article-title":"Enzymological diagnosis of a group of lysosomal storage diseases: a review of 5 years experience of 1600 patient sample referrals to a comprehensive laboratory programme in Australia","author":"Pollard A. C.","year":"1980","journal-title":"Med. J. Aust."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02534112"},{"key":"e_1_2_1_14_1","unstructured":"Refsum S.(1975)Heredopathia atactica poly\u2010neuritiformis. Phytanic acid storage disease (Refsum's disease).Handbook of Clinical Neurology Vol. 21 pp.181\u2013229."},{"key":"e_1_2_1_15_1","unstructured":"Shapiro L. R. J.Desnick R.Gold&M. M.Kaback(1979)Round table discussion on Genetic Screening for Disease Prevention International Symposium on lysosomes and lysosomal storage disease Toronto."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(69)90275-7"},{"key":"e_1_2_1_17_1","first-page":"688","volume-title":"The Metabolic Basis of Inherited Disease","author":"Steinberg D.","year":"1978"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.156.3783.1740"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0004.1981.tb01029.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0004.1981.tb01029.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T19:51:01Z","timestamp":1699645861000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0004.1981.tb01029.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,10]]}},"alternative-id":["10.1111\/j.1399-0004.1981.tb01029.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0004.1981.tb01029.x","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,10]]}}}